Shares of Acambis took a beating after the company announced it was no longer in the competition for a U.S. contract to provide smallpox vaccine. Its stock plunged 39 percent after company officials said it was no longer being considered. Acambis said that it would arrange a meeting with government officials to "seek clarification." "We are surprised that the U.S. government would eliminate Acambis," CEO Gordon Cameron said. "We believe that our proposal would have met the requirements."
- here's the International Herald Tribune report [1] on Acambis
Related Articles:
Acambis completes vaccine BLA. Report [2]
Acambis researching single-shot solution to flu. Report [3]
Links:
[1] http://www.iht.com/articles/ap/2006/11/14/business/EU_FIN_COM_Britain_Acambis.php
[2] http://www.fiercebiotech.com/story/spotlight-acambis-completes-vaccine-bla/2006-04-19
[3] http://www.fiercebiotech.com/story/acambis-researching-single-shot-solution-to-flu/2005-08-04